Wells Fargo Upgrades Johnson & Johnson (JNJ) to Outperform; Pharma Pipeline Moves To Forefront As Consumer Risk Dissipates
Go back to Wells Fargo Upgrades Johnson & Johnson (JNJ) to Outperform; Pharma Pipeline Moves To Forefront As Consumer Risk Dissipates| Johnson & Johnson (NYSE: JNJ) | Delayed: 271.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.11 | 52 Week High | $126.07 | |||
| Open | $271.11 | 52 Week Low | $94.28 | |||
| Day High | $271.11 | P/E | 56.36 | |||
| Day Low | $271.11 | EPS | $4.81 | |||
| Volume | 20,902 | |||||

